These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical evaluation of interval contraception by norethindrone acetate implant. Shahani SM; Kulkarni PP Indian J Med Res; 1982 Oct; 76():561-4. PubMed ID: 7152564 [No Abstract] [Full Text] [Related]
9. Effect of low dose norethindrone acetate released through subdermal silastic implant on lipid metabolism in female rhesus monkeys. Yadava HS; Kochar J; Laumas KR Indian J Exp Biol; 1978 Feb; 16(2):160-1. PubMed ID: 98430 [No Abstract] [Full Text] [Related]
10. Clinical experience with implant contraception. Coutinho E Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074 [TBL] [Abstract][Full Text] [Related]
11. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment. Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011 [TBL] [Abstract][Full Text] [Related]
12. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats. Doyle LL Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155 [TBL] [Abstract][Full Text] [Related]
13. Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. Hillier SG; Jha P; Griffiths K; Laumas KR Contraception; 1977 Apr; 15(4):473-88. PubMed ID: 880821 [TBL] [Abstract][Full Text] [Related]
14. [Effect of daily oral administration of 0.350 mg of norethindrone on lactation and on the composition of milk]. Giner Velázquez J; Cortés Gallegos V; Sotelo López A; Bondani G Ginecol Obstet Mex; 1976 Jul; 40(237):31-9. PubMed ID: 780215 [No Abstract] [Full Text] [Related]
15. Metabolic and endocrine studies in women using norethindrone acetate implant. Shahani SM; Kulkarni PP; Bhate PA; Patel KL Contraception; 1979 Feb; 19(2):135-44. PubMed ID: 428230 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of norethindrone in rabbits after administration of norethindrone acetate in single, double and quadruple doses released through subcutaneous silastic implants. Sarkar NN; Laumas V; Laumas KR Endocrinol Jpn; 1980 Oct; 27(5):653-8. PubMed ID: 7238423 [TBL] [Abstract][Full Text] [Related]
17. Hormonal implants: contraception for a new century. Darney PD Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903 [TBL] [Abstract][Full Text] [Related]
18. Serum norethindrone levels and menstrual pattern after the use of norethindrone implants in rhesus monkeys. Jha P; Murugesan K; Farooq A Contraception; 1995 Feb; 51(2):117-20. PubMed ID: 7750289 [TBL] [Abstract][Full Text] [Related]
19. Circulating levels of norethindrone in women with a single silastic implant. Goyal V; Joshi UM; Naik VK Contraception; 1978 Apr; 17(4):375-82. PubMed ID: 648158 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate. Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]